SAGE THERAPEUTICS, I
SAGE
 Delayed - 02/26 04:00:01 pm |
|
| 85USD | +1.86% |
Upcoming events on SAGE THERAPEUTICS, INC.
| 03/01/21 | 04:00pm | Cowen & Co. Health Care Conference |
| 05/06/21 | Q1 2021 Earnings Release (Projected) |
| 08/10/21 | Interim 2021 Earnings Release (Projected) |
| 11/04/21 | Q3 2021 Earnings Release (Projected) |
Past events on SAGE THERAPEUTICS, INC.
| 02/25/21 | 08:00am | SVB Leerink Global Healthcare Conference |
| 02/24/21 | 08:00am | FY 2020 Earnings Call |
| 02/24/21 | FY 2020 Earnings Release |
| 01/12/21 | 10:50am | JP Morgan Healthcare Conference |
Upcoming sector events for SAGE THERAPEUTICS, INC.
| 02/26/21 | 04:35pm | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 010 |
| 02/26/21 | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 290 |
| 02/26/21 | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 447 |
| 02/26/21 | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 425 |
Past sector events for SAGE THERAPEUTICS, INC.
| 02/25/21 | 01:40pm | GILEAD SCIENCES, INC. : SVB Leerink Global Healthcare Conference |
| 02/25/21 | 01:40pm | EXACT SCIENCES CORPORATION : SVB Leerink Global Healthcare Conference |
| 02/25/21 | IOVANCE BIOTHERAPEUTICS, INC. : FY 2020 Earnings Release |
| 02/25/21 | VIR BIOTECHNOLOGY, INC. : FY 2020 Earnings Release |
Annual results
 Previous year | Next Year |
| Annual results | 2020 | 2021 (e) | |
| Sales M $ |
Released Forecast Spread | 1 114 7,04 15 717% | 23,0 |
| Operating income (EBITDA) M $ |
Released Forecast Spread | 627 -479 231% | -234 |
| Operating profit (EBIT) M $ |
Released Forecast Spread | 624 -483 229% | -454 |
| Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 606 -471 229% | -450 |
| Net income M $ |
Released Forecast Spread | 606 -473 228% | -444 |
| EPS $ |
Released Forecast Spread | 11,4 -9,07 226% | -7,78 |
| Announcement Date | 02/24/2021 | ||
Quarterly / Semiannualy publications
| Previous period | Next period |
| Quarterly results | 2020 Q4 | 2021 Q1 (e) | |
| Sales M $ |
Released Forecast Spread | 1 109 10,1 10 843% | 1,91 |
| Operating income (EBITDA) M $ |
Released Forecast Spread | 974 -113 964% | 349 |
| Operating profit (EBIT) M $ |
Released Forecast Spread | 974 -48,5 2 106% | -113 |
| Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 975 -30,8 3 268% | -107 |
| Net income M $ |
Released Forecast Spread | 975 -115 951% | -109 |
| EPS $ |
Released Forecast Spread | 18,2 -1,05 1 828% | -1,94 |
| Announcement Date | 02/24/2021 | ||
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
